Surveillance after Total Neoadjuvant Therapy: What to do for Near-Complete Responders

Area of Science:

• Oncology
• Gastroenterology
• Surgical Oncology

Background:

• Total neoadjuvant therapy (TNT) is increasingly used for rectal cancer.
• A subset of patients achieve a near-complete response (nCR) after TNT.
• Optimal management for nCR rectal cancer patients remains controversial.

Purpose of the Study:

• To review therapeutic strategies for rectal cancer patients with nCR post-TNT.
• To examine surveillance options for this patient group.
• To synthesize relevant outcomes data for informed decision-making.

Main Methods:

• Literature review of studies on rectal cancer management after TNT.
• Analysis of therapeutic interventions and surveillance protocols.
• Evaluation of clinical outcomes, including recurrence and survival rates.

Main Results:

• Heterogeneity in current management approaches for nCR rectal cancer.
• Limited high-quality data comparing different post-TNT strategies.
• Emerging evidence on the safety and efficacy of watch-and-wait versus surgical resection.

Conclusions:

• Individualized treatment planning is crucial for rectal cancer patients with nCR after TNT.
• Further research is needed to establish standardized guidelines.
• Balancing oncologic outcomes with quality of life is paramount.